Scarica l'app Stockscreener
9.90
1.00%
-0.10
Immucell Corp Borsa (ICCC) Ultime notizie
ImmuCell CorporationCommon Stock (ICCC) Stock Price, News, Quote & History - FinancialContent
ImmuCell Q2 2026 slides: revenue gains offset by margin pressure - Investing.com
ImmuCell Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: ImmuCell posts strong Q2 2026 sales growth, shares fall - Investing.com
ImmuCell Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
ImmuCell Reports Q2 2026 Results: Full Earnings Call Transcript - Sahm
ImmuCell (NASDAQ:ICCC) Announces Earnings Results, Beats Estimates By $0.15 EPS - MarketBeat
IMMUCELL CORP /DE/ Q2 2026: Revenue $7.19M, EPS $0.2— 10-Q Summary - TradingView
ImmuCell Corporation (ICCC) doubles profit on higher First Defense sales - Stock Titan
ImmuCell Plans About $4.5M Expansion for Calf Health Products - Stock Titan
ImmuCell Corp (ICCC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Calf-health company ImmuCell schedules Aug. 14 results webcast - Stock Titan
ImmuCell (ICCC) Expected to Release Earnings on Thursday - MarketBeat
ImmuCell Corp (ICCC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ImmuCell Corp (ICCC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ImmuCell Corp (ICCC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ICCC|ImmuCell Corp|Price:11.135|Chg%:+0.105 - TradingKey
ImmuCell Corp (ICCC) Cash Flow - TradingKey
ImmuCell Corp (ICCC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ImmuCell Corp (ICCC) Institutional Confidence - TradingKey
ImmuCell Corp (ICCC) Income Statement - TradingKey
ImmuCell Corp (ICCC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MSN Money - MSN
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH - RTTNews
ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand - Yahoo Finance
ImmuCell Corporation Files Form 8-K: Key Financial Data and Company Information for July 2026 - Minichart
ImmuCell reports 11.5% sales increase in second quarter - Investing.com
ImmuCell (ICCC) Reports Significant Growth in Quarterly Sales - GuruFocus
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results - The Manila Times
ImmuCell reports Q2 product sales up 11.5% to $7.2M; six‑month sales up 20.9% to $17.5M - TradingView
ImmuCell (ICCC) Q2 2026 sales hit $7.2M as six-month revenue climbs 20.9% - Stock Titan
ImmuCell sales jump 12% in Q2 as U.S. demand lifts calf products - Stock Titan
ImmuCell adds Jacee Lancaster to Commercial Team - Feedstuffs
ImmuCell Corporation (ICCC) Gains 1.39% as Stock Approaches Key Resistance at $10.70Inverse ETF Flow - dars.gov.et
ICCC's valuation remains premium: Is it worth overpaying for? - MSN
The Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCell - Yahoo Finance
ImmuCell CEO buys $75,960 in common stock - Investing.com UK
Insider Buying: te Boekhorst Paul Francis Olivier Acquires Additional Shares of ImmuCell Corp (ICCC) - GuruFocus
Form 4 ImmuCell Corporation For: 22 June By Investing.com - Investing.com Nigeria
ImmuCell CEO buys $75,960 in common stock By Investing.com - Investing.com Canada
ImmuCell (ICCC) CEO increases stake with 8,000-share open-market buy - Stock Titan
ICCC's Valuation Remains Premium: Is it Worth Overpaying for? - The Globe and Mail
ImmuCell shareholders approve director elections and key proposals at annual meeting - Investing.com
ImmuCell (NASDAQ: ICCC) investors approve directors, pay plan, auditor - Stock Titan
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):